Immune modulating effects of β-glucan

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 13, Issue 6, 2010, Pages 656-661

  Murphy, E Angela ^a   Davis, J Mark ^b   Carmichael, Martin D ^b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

cancer; immune function; infection; nutrition

Indexed keywords

BETA GLUCAN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CELL ACTIVATION; CHEMICAL STRUCTURE; CHEMOEMBOLIZATION; COLORECTAL CANCER; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOMODULATION; LIVER CELL CARCINOMA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PANCREAS CANCER; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REVIEW; SACCHAROMYCES CEREVISIAE; SCIENTIFIC LITERATURE; STOMACH CANCER; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BETA-GLUCANS; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC FACTORS; INFECTION; NEOPLASMS;

EID: 78149279932     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32833f1afb     Document Type: Review

References (55)

1. Thornton BP, Vetvicka V, Pitman M, et al. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol 1996;156:1235-1246.
2. Rice PJ, Kelley JL, Kogan G, et al. Human monocyte scavenger receptors are pattern recognition receptors for (1 → 3)-beta-D-glucans. J Leukoc Biol 2002;72:140-146.
3. Zimmerman JW, Lindermuth J, Fish PA, et al. A novel carbohydrate- glycosphingolipid interaction between a beta-(1 → 3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J Biol Chem 1998;273:22014-22020.
4. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 2001;413:36-37.
5. Goodridge HS, Wolf AJ, Underhill DM. Beta-glucan recognition by the innate immune system. Immunol Rev 2009;230:38-50.
6. LeBlanc BW, Albina JE, Reichner JS. The effect of PGG-beta-glucan on neutrophil chemotaxis in vivo. J Leukoc Biol 2006;79:667-675.
7. Xia Y, Borland G, Huang J, et al. Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion. J Immunol 2002;169:6417-6426.
8. Li B, Allendorf DJ, Hansen R, et al. Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Sykphosphatidylinositol 3-kinase pathway. J Immunol 2006;177:1661-1669.
9. van Bruggen R, Drewniak A, Jansen M, et al. Complement receptor 3, not • Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. Mol Immunol 2009;47:575-581. There has been some controversy about the relative importance of various receptors on the immune response to β-glucan. This study showed that phagocytosis of β-glucan by neutrophils was completely dependent on complement receptor 3 and not dectin-1. This study provides support for a dissimilar response in recognition of β-glucan among species.
10. Pluddemann A, Neyen C, Gordon S. Macrophage scavenger receptors and host-derived ligands. Methods 2007;43:207-217.
11. Hahn PY, Evans SE, Kottom TJ, et al. Pneumocystis carinii cell wall betaglucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. J Biol Chem 2003;278:2043-2050.
12. Evans SE, Hahn PY, McCann F, et al. Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factorkappaB-dependent mechanisms. Am J Respir Cell Mol Biol 2005;32:490-497.
13. Sato T, Iwabuchi K, Nagaoka I, et al. Induction of human neutrophil chemotaxis by Candida albicans-derived beta-1, 6-long glycoside side-chain-branched beta-glucan. J Leukoc Biol 2006;80:204-211.
14. Tsoni SV, Brown GD. Beta-glucans and dectin-1. Ann N Y Acad Sci 2008;1143:45-60.
15. Willment JA, Marshall AS, Reid DM, et al. The human beta-glucan receptor is widely expressed and functionally equivalent to murine dectin-1 on primary cells. Eur J Immunol 2005;35:1539-1547.
16. Werner JL, Metz AE, Horn D, et al. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 2009;182:4938-4946.
17. Mallick SK, Maiti S, Bhutia SK, Maiti TK. Immunostimulatory properties of a polysaccharide isolated from Astraeus hygrometricus. J Med Food 2010;13:665-672.
18. Saijo S, Fujikado N, Furuta T, et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 2007;8:39-46.
19. Davis JM, Murphy EA, Brown AS, et al. Effects of oat beta-glucan on innate immunity and infection after exercise stress. Med Sci Sports Exerc 2004;36:1321-1327.
20. Murphy EA, Davis JM, Carmichael MD, et al. Benefits of oat beta-glucan and sucrose feedings on infection and macrophage antiviral resistance following exercise stress. Am J Physiol Regul Integr Comp Physiol 2009;297:R1188-R1194.
21. Murphy EA, Davis JM, Brown AS, et al. Oat beta-glucan effects on neutrophil respiratory burst activity following exercise. Med Sci Sports Exerc 2007;39:639-644.
22. Miura T, Ohno N, Miura NN, et al. Antigen-specific response of murine immune system toward a yeast beta-glucan preparation, zymosan. FEMS Immunol Med Microbiol 1999;24:131-139.
23. Inoue A, Kodama N, Nanba H. Effect of maitake (Grifola frondosa) D-fraction on the control of the T lymph node Th-1/Th-2 proportion. Biol Pharm Bull 2002;25:536-540.
24. Chang ZQ, Reza MA, Lee JS, et al. Immunomodulatory activities and subacute toxicity of a novel beta-glucan from Paenibacillus polymyxa JB115 in rats. Immunopharmacol Immunotoxicol 2010. [Epub ahead of print]
25. Berner MD, Sura ME, Alves BN, Hunter KW Jr. IFN-gamma primes macrophages for enhanced TNF-alpha expression in response to stimulatory and nonstimulatory amounts of microparticulate beta-glucan. Immunol Lett 2005;98:115-122.
26. Drandarska I, Kussovski V, Nikolaeva S, Markova N. Combined immunomodulating effects of BCG and lentinan after intranasal application in guinea pigs. Int Immunopharmacol 2005;5:795-803.
27. Nameda S, Harada T, Miura NN, et al. Enhanced cytokine synthesis of leukocytes by a beta-glucan preparation, SCG, extracted from a medicinal mushroom, Sparassis crispa. Immunopharmacol Immunotoxicol 2003;25:321-335.
28. Nieman DC, Henson DA, McMahon M, et al. Beta-glucan, immune function, and upper respiratory tract infections in athletes. Med Sci Sports Exerc 2008;40:1463-1471.
29. Thompson IJ, Oyston PC, Williamson DE. Potential of the beta-glucans to enhance innate resistance to biological agents. Expert Rev Anti Infect Ther 2010;8:339-352.
30. Murphy EA, Davis JM, Brown AS, et al. Benefits of oat beta-glucan on respiratory infection following exercise stress: role of lung macrophages. Am J Physiol Regul Integr Comp Physiol 2008;294:R1593-R1599.
31. Markova N, Kussovski V, Drandarska I, et al. Protective activity of lentinan in experimental tuberculosis. Int Immunopharmacol 2003;3:1557-1562.
32. Hetland G, Ohno N, Aaberge IS, Lovik M. Protective effect of beta-glucan against systemic Streptococcus pneumoniae infection in mice. FEMS Immunol Med Microbiol 2000;27:111-116.
33. Wang SC, Bligh SW, Zhu CL, et al. Sulfated beta-glucan derived from oat bran with potent anti-HIV activity. J Agric Food Chem 2008;56:2624-2629.
34. 3. J Med 1995;26:193-207.
35. Gordon M, Bihari B, Goosby E, et al. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. J Med 1998;29:305-330.
36. Babineau TJ, Marcello P, Swails W, et al. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann Surg 1994;220:601-609.
37. De Felippe Junior J, da Rocha e Silva Junior M, Maciel FM, et al. Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1!3 polyglucose (glucan). Surg Gynecol Obstet 1993;177:383-388.
38. Murphy EA, Davis JM, Brown AS, et al. Effects of moderate exercise and oat beta-glucan on lung tumor metastases and macrophage antitumor cytotoxicity. J Appl Physiol 2004;97:955-959.
39. McCormack E, Skavland J, Mujic M, et al. Lentinan: hematopoietic, immunological, and efficacy studies in a syngeneic model of acute myeloid leukemia. Nutr Cancer 2010;62:574-583.
40. Niu YC, Liu JC, Zhao XM, et al. Immunostimulatory activities of a low molecular weight antitumoral polysaccharide isolated from Agaricus blazei Murill (LMPAB) in Sarcoma 180 ascitic tumor-bearing mice. Pharmazie 2009;64:472-476.
41. Chan GC, Chan WK, Sze DM. The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol 2009;2:25.
42. Sze DM, Chan GC. Supplements for immune enhancement in hematologic malignancies. Hematology Am Soc Hematol Educ Program 2009; pp. 313-319.
43. Yoon TJ, Kim TJ, Lee H, et al. Antitumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae. Int Immunopharmacol 2008;8:36-42.
44. Tang W, Liu JW, Zhao WM, et al. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci 2006;80:205-211.
45. Muller CI, Kumagai T, O'Kelly J, et al. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res 2006;30:841-848.
46. Demir G, Klein HO, Mandel-Molinas N, Tuzuner N. Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer. Int Immunopharmacol 2007;7:113-116.
47. Shimizu K, Shimizu K, Watanabe S, Matsuda K, et al. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer. Hepatogastroenterology 2009;56:240-244.
48. Hazama S, Watanabe S, Ohashi M, et al. Efficacy of orally administered • superfine dispersed lentinan (beta-1, 3-glucan) for the treatment of advanced colorectal cancer. Anticancer Res 2009;29:2611-2617. This study assessed the efficacy of β-glucan from lentinin on quality of life scores in advanced colorectal cancer patients. Patients with low quality of life scores (n = 23) reported a significant improvement in their score following 12 weeks of β-glucan treatment. The binding of peripheral blood monocytes to β-glucan appeared to be a predictor of quality of life improvement.
49. + monocytes was a promising prognostic predictor; survival time of the lentinin-high-binding group was significantly longer than that of the lentinin-low-binding group.
50. Oba K, Kobayashi M, Matsui T, et al. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anticancer Res 2009;29:2739-2745.
51. Kataoka H, Shimura T, Mizoshita T, et al. Lentinan with S-1 and paclitaxel for • gastric cancer chemotherapy improve patient quality of life. Hepatogastroenterology 2009;56:547-550. This study showed that lentinin combined with cancer chemotherapy throughout the treatment period can improve quality of life in gastric cancer patients.
52. Inoue M, Tanaka Y, Sugita N, et al. Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study. Biotherapy 1993;6:13-18.
53. Kodama N, Komuta K, Nanba H. Can maitake MD-fraction aid cancer patients? Altern Med Rev 2002;7:236-239.
54. Yang P, Liang M, Zhang Y, Shen B. Clinical application of a combination therapy of lentinan, multielectrode RFA and TACE in HCC Adv Ther 2008;25:787-794.
55. Zhong W, Hansen R, Li B, et al. Effect of yeast-derived beta-glucan in • conjunction with bevacizumab for the treatment of human lung adenocarcinoma in subcutaneous and orthotopic xenograft models. J Immunother 2009;32:703-712. This study reported that β-glucan enhances the efficacy of benacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), in terms of tumor progression and long-term survival in a xenograft model of human lung adenocarcinoma. The authors suggest that this combination therapy may provide clinical benefits for human lung cancer patients